Abstract
This perspective paper examines the challenges of implementing regenerative medicine therapies within clinical delivery systems. Drawing on recent work in the social sciences, the paper highlights dynamics within existing healthcare systems that will present both hindrances and affordances for the implementation of new regenerative medicine technologies within hospitals and clinics. The paper argues that identifying suitable locations for cell and gene therapy treatment centres requires an assessment of their Institutional Readiness for regenerative medicine. Some provisional criteria for assessing Institutional Readiness are outlined, and the paper will suggest that it is necessary to begin developing a programme for the phased introduction of regenerative medicine in the longer term.
| Original language | English |
|---|---|
| Pages (from-to) | 29–39 |
| Number of pages | 11 |
| Journal | Regenerative Medicine |
| Volume | 13 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2018 |
Keywords
- commissioning
- GMP
- hospitals
- institutional readiness
- National Health Service
- risk-sharing
- technology adoption